These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
539 related articles for article (PubMed ID: 35017177)
21. NK cells clear α-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of α-synucleinopathy. Earls RH; Menees KB; Chung J; Gutekunst CA; Lee HJ; Hazim MG; Rada B; Wood LB; Lee JK Proc Natl Acad Sci U S A; 2020 Jan; 117(3):1762-1771. PubMed ID: 31900358 [TBL] [Abstract][Full Text] [Related]
22. A simple, versatile and robust centrifugation-based filtration protocol for the isolation and quantification of α-synuclein monomers, oligomers and fibrils: Towards improving experimental reproducibility in α-synuclein research. Kumar ST; Donzelli S; Chiki A; Syed MMK; Lashuel HA J Neurochem; 2020 Apr; 153(1):103-119. PubMed ID: 31925956 [TBL] [Abstract][Full Text] [Related]
23. Liquid-liquid Phase Separation of α-Synuclein: A New Mechanistic Insight for α-Synuclein Aggregation Associated with Parkinson's Disease Pathogenesis. Mukherjee S; Sakunthala A; Gadhe L; Poudyal M; Sawner AS; Kadu P; Maji SK J Mol Biol; 2023 Jan; 435(1):167713. PubMed ID: 35787838 [TBL] [Abstract][Full Text] [Related]
24. α-Synuclein in Parkinson's Disease: Does a Prion-Like Mechanism of Propagation from Periphery to the Brain Play a Role? Zheng H; Shi C; Luo H; Fan L; Yang Z; Hu X; Zhang Z; Zhang S; Hu Z; Fan Y; Yang J; Mao C; Xu Y Neuroscientist; 2021 Aug; 27(4):367-387. PubMed ID: 32729773 [TBL] [Abstract][Full Text] [Related]
25. Non-invasive systemic viral delivery of human alpha-synuclein mimics selective and progressive neuropathology of Parkinson's disease in rodent brains. Bérard M; Martínez-Drudis L; Sheta R; El-Agnaf OMA; Oueslati A Mol Neurodegener; 2023 Nov; 18(1):91. PubMed ID: 38012703 [TBL] [Abstract][Full Text] [Related]
26. Targeting alpha-synuclein for the treatment of Parkinson's disease. Rohn TT CNS Neurol Disord Drug Targets; 2012 Mar; 11(2):174-9. PubMed ID: 22483285 [TBL] [Abstract][Full Text] [Related]
27. Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of PD brains. Longhena F; Faustini G; Varanita T; Zaltieri M; Porrini V; Tessari I; Poliani PL; Missale C; Borroni B; Padovani A; Bubacco L; Pizzi M; Spano P; Bellucci A Brain Pathol; 2018 Nov; 28(6):875-888. PubMed ID: 29330884 [TBL] [Abstract][Full Text] [Related]
28. Ellagic Acid Prevents α-Synuclein Aggregation and Protects SH-SY5Y Cells from Aggregated α-Synuclein-Induced Toxicity via Suppression of Apoptosis and Activation of Autophagy. Ardah MT; Eid N; Kitada T; Haque ME Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948195 [TBL] [Abstract][Full Text] [Related]
29. Development of an α-synuclein fibril and oligomer specific tracer for diagnosis of Parkinson's disease, dementia with Lewy bodies and multiple system atrophy. Sevenich M; Honold D; Willuweit A; Kutzsche J; Mohrlüder J; Willbold D Neurochem Int; 2022 Dec; 161():105422. PubMed ID: 36252819 [TBL] [Abstract][Full Text] [Related]
30. HTRA1 disaggregates α-synuclein amyloid fibrils and converts them into non-toxic and seeding incompetent species. Chen S; Puri A; Bell B; Fritsche J; Palacios HH; Balch M; Sprunger ML; Howard MK; Ryan JJ; Haines JN; Patti GJ; Davis AA; Jackrel ME Nat Commun; 2024 Mar; 15(1):2436. PubMed ID: 38499535 [TBL] [Abstract][Full Text] [Related]
31. Lewy-like aggregation of α-synuclein reduces protein phosphatase 2A activity in vitro and in vivo. Wu J; Lou H; Alerte TN; Stachowski EK; Chen J; Singleton AB; Hamilton RL; Perez RG Neuroscience; 2012 Apr; 207():288-97. PubMed ID: 22326202 [TBL] [Abstract][Full Text] [Related]
32. Pathogenesis of α-Synuclein in Parkinson's Disease: From a Neuron-Glia Crosstalk Perspective. Yi S; Wang L; Wang H; Ho MS; Zhang S Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499080 [TBL] [Abstract][Full Text] [Related]